1. Normal response to tumor necrosis factor-alpha and transforming growth factor-beta by keratinocytes in psoriasis
- Author
-
Lionel Fry, J.J. Garioch, Angeli K. Malkani, Helgi Valdimarsson, B.S. Baker, A.V. Powles, and Helen M. Lewis
- Subjects
Adult ,Keratinocytes ,medicine.medical_specialty ,medicine.medical_treatment ,Dermatology ,Biochemistry ,Receptors, Tumor Necrosis Factor ,Transforming Growth Factor beta ,In vivo ,Internal medicine ,Psoriasis ,medicine ,Humans ,Lymphocytes ,Molecular Biology ,Skin ,Cell Nucleus ,biology ,Tumor Necrosis Factor-alpha ,Macrophages ,Nuclear Proteins ,Transforming growth factor beta ,medicine.disease ,In vitro ,Endocrinology ,Cytokine ,biology.protein ,Tumor necrosis factor alpha ,Antibody ,Cell Division ,Transforming growth factor - Abstract
Normal and chronic plaque psoriatic keralinocyte cultures were tested for their in vitro response to 2–200 ng/nil TNF-α and 0.1–10 ng/ml TGF-β in a serum-free culture system. All normal and lesional psoriatic epidermal cell cultures showed a dose- and lime-dependent inhibition of growth in response to TNF-α and TGF-β. Inhibition in individual cultures was first seen at a concentration of 2 ng/ml for TNF-α and 0.1 ng/ml for TGF-β at day 2, but became significant at 20 ng/ml and 1 ng/ ml for TNF-α and TGF-β respectively at days 2-6. This effect was statistically significant at days 3–4 for the group of normal (TNF-α and TGF-β, n = 10, p
- Published
- 1993